Lembo Chiara, Buonocore Giuseppe, Perrone Serafina
Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.
Department of Medicine and Surgery, Neonatology Unit, University of Parma, 43126 Parma, Italy.
Antioxidants (Basel). 2021 Oct 23;10(11):1672. doi: 10.3390/antiox10111672.
Preterm babies are highly susceptible to oxidative stress (OS) due to an imbalance between the oxidant and antioxidant systems. The generation of free radicals (FR) induces oxidative damage to multiple body organs and systems. OS is the main factor responsible for the development of typical premature infant diseases, such as bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage, periventricular leukomalacia, kidney damage, eryptosis, and also respiratory distress syndrome and patent ductus arteriosus. Many biomarkers have been detected to early identify newborns at risk of developing a free radical-mediated disease and to investigate new antioxidant strategies. This review reports the current knowledge on OS in the preterm newborns and the newest findings concerning the use of OS biomarkers as diagnostic tools, as well as in implementing antioxidant therapeutic strategies for the prevention and treatment of these diseases and their sequelae.
由于氧化和抗氧化系统之间的失衡,早产儿极易受到氧化应激(OS)的影响。自由基(FR)的产生会对身体多个器官和系统造成氧化损伤。氧化应激是导致典型早产儿疾病(如支气管肺发育不良、早产儿视网膜病变、坏死性小肠结肠炎、脑室内出血、脑室周围白质软化、肾损伤、红细胞凋亡)以及呼吸窘迫综合征和动脉导管未闭的主要因素。已经检测到许多生物标志物,用于早期识别有患自由基介导疾病风险的新生儿,并研究新的抗氧化策略。本综述报告了关于早产儿氧化应激的当前知识,以及关于使用氧化应激生物标志物作为诊断工具的最新发现,以及在实施抗氧化治疗策略以预防和治疗这些疾病及其后遗症方面的最新发现。